1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Asparaginase Market – By Type

1.3.2        North America Asparaginase Market – By Application

1.3.3        North America Asparaginase Market – By End-Use Industry

1.3.4        North America Asparaginase Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Asparaginase Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Asparaginase Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Incidences of Leukemia and Increasing Usage Application

5.1.2        Rapid Growth of the Pharmaceutical and Food Industry

5.2         Market Restraints

5.2.1        Side Effects Associated With Use of Asparaginase

5.3         Market Opportunities

5.3.1        New Product Launches and Approvals

5.3.2

5.4         Future Trends

5.4.1        Increase in R&D Activities and Investment by Market Players

5.5         Impact Analysis

6.           Asparaginase Market– North America Analysis

6.1         North America Asparaginase Market Revenue Forecasts and Analysis

7.           North America Asparaginase Market Analysis – By Type

7.1         Overview

7.2         By Type: North America Market Revenue and Forecast Analysis (US$ Million)

7.2.1        Escherichia Coli

7.2.1.1          Overview

7.2.1.2          Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

7.2.2        Erwinia Chrysanthemi

7.2.2.1          Overview

7.2.2.2          Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

7.2.3        Pegylated

7.2.3.1          Overview

7.2.3.2          Pegylated Market Revenue and Forecast to 2028 (US$ Million)

7.2.4        Others

7.2.4.1          Overview

7.2.4.2          Others Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Asparaginase Market Analysis – By Application

8.1         Overview

8.2         By Application: North America Market Revenue and Forecast Analysis (US$ Million)

8.2.1        Therapeutic

8.2.1.1          Overview

8.2.1.2          Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3          Acute Lymphoblastic Leukaemia (ALL)

8.2.1.3.1          Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4          Lymphoblastic Lymphoma (LBL)

8.2.1.4.1          Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.5          Others

8.2.1.5.1          Others Market Revenue and Forecast to 2028 (US$ Million)

8.2.2        Food Processing

8.2.2.1          Overview

8.2.2.2          Food Processing Market Revenue and Forecast to 2028 (US$ Million)

8.2.3        Others

8.2.3.1          Overview

8.2.3.2          Others Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Asparaginase Market Analysis – By End-use Industry

9.1         By End-Use: North America Market Revenue and Forecast Analysis (US$ Million)

9.1.1        Healthcare

9.1.1.1          Overview

9.1.1.2          Healthcare Market Revenue and Forecast to 2028 (US$ Million)

9.1.2        Food Manufacturing

9.1.2.1          Overview

9.1.2.2          Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Asparaginase Market – Country Analysis

10.1      Overview

10.1.1     North America: Asparaginase Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.1.3       US: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.1.4       US: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.1.4.1    US: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.1.5       US: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.1.2       Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.2.3       Canada: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.2.4       Canada: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.2.4.1    Canada: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.2.5       Canada: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

10.1.1.3       Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.1.3.3       Mexico: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)

10.1.1.3.4       Mexico: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)

10.1.1.3.4.1    Mexico: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)

10.1.1.3.5       Mexico: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)

11.        Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Servier Pharmaceuticals LLC

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Biovendor, LLC

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Creative Enzymes

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Taj Pharmaceuticals Limited

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.5      medac GMBH

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Jazz Pharmaceuticals, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Changzhou Qianhong Biopharma Co Ltd

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      United Biotech (P) Limited

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)

Table 2.             US: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             US: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             US: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             US: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Canada: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Canada: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Canada: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Canada: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Mexico: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          Mexico: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          Mexico: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Mexico: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14.          Recent Inorganic Growth Strategies

Table 15.          Recent Organic Growth Strategies

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Asparaginase Market Segmentation

Figure 2.           North America Asparaginase Market Segmentation, by Country

Figure 3.           North America Asparaginase Market Overview

Figure 4.           North America Asparaginase Market, By Type

Figure 5.           North America Asparaginase Market, By Country

Figure 7.           North America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           North America Asparaginase Market Impact Analysis of Drivers and Restraints

Figure 10.        North America Asparaginase Market – Revenue Forecasts and Analysis

Figure 11.        By Type: North America Market Analysis and Forecast 2021 and 2028 (%)

Figure 12.        North America Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Pegylated Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        By Application: North America Market Analysis and Forecast 2021 and 2028 (%)

Figure 17.        North America Therapeutic Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Food Processing Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        By End-Use: North America Market Analysis and Forecast 2021 and 2028 (%)

Figure 24.        North America Healthcare Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America: Asparaginase Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27.        North America: Asparaginase Market, by Country, 2021 & 2028 (%)

Figure 28.        US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 29.        Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30.        Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)